ES / EN
- June 13, 2026 -
No Result
View All Result
OnCubaNews
  • World
  • Cuba
  • Cuba-USA
  • Opinion
    • Columns
    • Infographic
  • Culture
    • Billboard
  • Sports
  • Styles / Trends
  • Media
  • Special
  • Cuban Flavors
  • World
  • Cuba
  • Cuba-USA
  • Opinion
    • Columns
    • Infographic
  • Culture
    • Billboard
  • Sports
  • Styles / Trends
  • Media
  • Special
  • Cuban Flavors
OnCubaNews
ES / EN
Home Cuba Science Health in Cuba

Cuba develops device for visual and auditory screening of newborns

Telecommunications Engineer Ernesto Velarde, one of the project leaders, pointed out that hearing tests are carried out in the island’s maternal hospitals with otoacoustic emission equipment, which are imported.

by
  • OnCuba Staff
    OnCuba Staff
June 17, 2021
in Health in Cuba
0
Photo: Ariel Cecilio Lemus/ACN.

Photo: Ariel Cecilio Lemus/ACN.

The Cuban Neuroscience Center (CNEURO) developed a neonatal screening system, called Infantix, to detect hearing and vision disorders in newborns.

Telecommunications Engineer Ernesto Velarde, one of the project leaders, pointed out that hearing tests are carried out in the island’s maternal hospitals with otoacoustic emission equipment, which are imported, according to the Agencia Cubana de Noticias news agency.

The specialist underlined that none of these technologies in the world has incorporated visual screening among its functions. In contrast, the device developed by CNEURO does.

https://twitter.com/cneuro_cuba/status/1405124732442316801?ref_src=twsrc%5Etfw%7Ctwcamp%5Etweetembed%7Ctwterm%5E1405124732442316801%7Ctwgr%5E%7Ctwcon%5Es1_&ref_url=https%3A%2F%2Foncubanews.com%2Fcuba%2Fcuba-desarrolla-un-dispositivo-para-realizar-pesquisa-visual-y-auditiva-a-recien-nacidos%2F

Registered in 2019 by the Center for State Control of Medicines, Equipment and Medical Devices (CECMED) to carry out auditory screenings, and visual para-analysis in 2020, the device has an accessory that has microphones and loudspeakers to emit sounds and receive their echo. This is due to the fact that this rebound provides information on the functioning of the child’s middle and inner ear that the Infantix analyzes, Velarde explained.

For the visual evoked potential test, the patient receives a visual stimulus and the system evaluates the brain’s response to that stimulation, the specialist explained.

Related Posts

Center for Molecular Immunology

Non-alpha IL-2 Mutein: a Cuban hope for cancer

May 11, 2025
Dr. Tareq Zaid with a patient. Photo: Courtesy of the interviewee.

Dr. Tareq: the story of a Palestinian-Cuban doctor

March 3, 2025
Photo: Canva.

Psychosomatic illnesses: Can the mind make the body sick?

November 10, 2024
Itolizumab. Photo taken from Radio Habana Cuba

Itolizumab, the monoclonal antibody designed in Cuba, is making its way into the world

October 25, 2024

“In this way, it is possible to measure from the retina, the optic nerve, to the part of the brain’s cortex that is responsible for visual processing,” said the engineer, who added that this type of research can detect major problems of the visual pathway such as congenital cataracts or visual nerve neuropathies.

The expert stated that the main purpose of his work is to detect as soon as possible any auditory or visual disorder; and in the specific case of hearing, the goal is for each newborn to leave the hospital with this test performed.

“If we are able to make an early diagnosis of any problem and refer to specialized care, these patients will have normal development during their life,” concluded Velarde.

  • OnCuba Staff
    OnCuba Staff
Tags: health system in Cuba
Previous Post

U.S. returns to Cuba 59 rafters intercepted in Florida Keys

Next Post

Travelers arriving in Cuba through Varadero and Cayo Coco must book tourism or isolation packages

OnCuba Staff

OnCuba Staff

Next Post
Photo: Yander Zamora/EFE/Archive.

Travelers arriving in Cuba through Varadero and Cayo Coco must book tourism or isolation packages

Photo: Kaloian Santos Cabrera.

Cuban government raises war veterans’ pensions

The director of the Finlay Vaccine Institute, Vicente Vérez, shows a vial of the Soberana 02 vaccine candidate in Havana. Photo: Ernesto Mastrascusa/EFE/Archive.

Cuban Soberana 02 vaccine candidate shows 62% efficacy in clinical trials

Leave a Reply Cancel reply

The conversation here is moderated according to OnCuba News discussion guidelines. Please read the Comment Policy before joining the discussion.

Your email address will not be published. Required fields are marked *

Most Read

  • The Enchanted Shrimp of the Cuban Dance

    6541 shares
    Share 2616 Tweet 1635
  • Cuba Needs a National Pact

    25 shares
    Share 10 Tweet 6
  • Vatican foreign minister arrives in Havana to meet with Díaz-Canel

    64 shares
    Share 26 Tweet 16
  • Mitsubishi considers new trade agreements with Cuba

    53 shares
    Share 21 Tweet 13
  • Marylin Monroe and Afro-Americans

    715 shares
    Share 286 Tweet 179

Most Commented

    • About us
    • Work with OnCuba
    • Terms of use
    • Privacy Policy
    • Moderation policy for comments
    • Contact us
    • Advertisement offers

    OnCuba and the OnCuba logo are registered® trademarks of Fuego Enterprises, Inc., its subsidiaries or divisions.
    OnCuba © by Fuego Enterprises, Inc. All Rights Reserved.

    No Result
    View All Result
    • World
    • Cuba
    • Cuba-USA
    • Opinion
      • Columns
      • Infographic
    • Culture
      • Billboard
    • Sports
    • Styles / Trends
    • Media
    • Special
    • Cuban Flavors

    OnCuba and the OnCuba logo are registered® trademarks of Fuego Enterprises, Inc., its subsidiaries or divisions.
    OnCuba © by Fuego Enterprises, Inc. All Rights Reserved.

    Manage Consent
    To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
    Functional Always active
    The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
    Preferences
    The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
    Statistics
    The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
    Marketing
    The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
    • Manage options
    • Manage services
    • Manage {vendor_count} vendors
    • Read more about these purposes
    View preferences
    • {title}
    • {title}
    • {title}